ADNI 4 (Alzheimer’s Disease Neuroimaging Initiative)

This study is sponsored by the NIH and will employ cutting-edge techniques to evaluate normal and pathological brain aging which could help change the future of Alzheimer’s disease. Poor memory is often viewed as a simple sign of getting older, complicating our understanding and treatment of Alzheimer's disease. For more than a decade, ADNI researchers have worked tirelessly to better understand the disease and its progression in a way that will help the development of future treatment options, though no experimental medication will be involved in this study.

Study Length:

The study is set to run up to 5 years depending on funding.

Disorder/Condition:

Alzheimer's Disease

Inclusion Criteria:

The study is open to both male and female subjects, aged 55-90 years.

Open to all ranges of cognitive function:

cognitively normal
Mild Cognitive Impairment (MCI)
Mild dementia due to Alzheimer’s

Study Title (brief):

ADNI 4 (Alzheimer’s Disease Neuroimaging Initiative)

Study Description (brief):

This study is sponsored by the NIH and will employ cutting-edge techniques to evaluate normal and pathological brain aging which could help change the future of Alzheimer’s disease. Poor memory is often viewed as a simple sign of getting older, complicating our understanding and treatment of Alzheimer's disease. For more than a decade, ADNI researchers have worked tirelessly to better understand the disease and its progression in a way that will help the development of future treatment options, though no experimental medication will be involved in this study.

Study Contact:

Antero Sarreal, MD at 845-398-6532 or asarreal@nki.rfmh.org [2].